Lexicon Pharmaceuticals (Nasdaq: LXRX) announced it has earned a third $10 million milestone payment in 2026 from Novo Nordisk A/S ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE